Nephro Care IPO opens for subscription from June 28 and ends on July 2, 2024. The IPO is a book-built issue of Rs. 41.26 crores. The issue is entirely fresh issue of 45.84 lakh equity shares. Price range of the issue is set to ₹85 to ₹90 per equity shares with face value of ₹10 each. The issue shall be listed on NSE SME (small and medium enterprises) with tempting date as fixed as Friday, July 5, 2024.
The minimum lot size of the issue is 1600 equity shares and in multiples thereof. The minimum amount of investments required for Retail is ₹1,44,000. The minimum bid size for HNI’s is 2 lots, aggregating to ₹2,88,000. Nephro Care has reserved 50% shares in the issue for QIB’s, 15% for NII’s and 35% for Retails.
ReadMoreTCS partners with Xerox to transform its IT Technology Using Cloud and GenAI
Corporate Capital Ventures Private Limited is book-running lead manager. HDFC Bank Limited is sponsor bank of the issue. Big Share Services Private Limited is registrar of the IPO.
Financials
| Particulars | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Revenue | 19.90 | 17.09 | 3.42 | 1.82 |
| Profit | 3.40 | 1.94 | -0.01 | 0.09 |
| PAT Margin | 17.09% | 11.36% | -0.29% | 4.94% |
| Cash Flow from Operations | 1.72 | 4.31 | 0.62 | 0.23 |
| Borrowings | – | 2.46 | 2.54 | 0.69 |
Risk Factors
- The company revenues are significantly dependent on it’s flagship Salt Lake clinic, any impact could materially affect it’s business.
- The control of company is handed to it’s promoter Dr. Pratim Sengupta.
Objects of the Issue
- Setting up a new Multi Specialty Hospital in the name of Vivacity Multi Specialty Hospital at Kolkata, West Bengal.
- General Corporate Expenses
About Nephro Care India Limited
Incorporated in 2014. Nephro Care India Limited is comprehensive treatment center located at Kolkata, offering clinic solutions and renal insufficiency treatment for patients.
